Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program.

N Murtha, H Morrison,M Roumeliotis,S Quirk,W Smith, A Blais

Medical physics（2023）

引用 0|浏览0

暂无评分

摘要

I therapy, PET-CT uptake, PET-SPECT injection, and orthovoltage therapy rooms were considered. The I treatment rooms were the best candidate for Lu-PSMA therapy, due to their shielding and capability to accommodate the necessary workflow.

查看译文

关键词

Lu-177,PSMA,prostate cancer,radiation shielding

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要